SLXN Wutah pendapatan triwulanan Silexion Therapeutics

Simbol lan logo merek silexion.com (SLXN)

Quarterly revenue growth dynamics highlight the efficiency of outsourcing molecule synthesis via CROs, while the 0.00 level records fresh values. Silexion Therapeutics Corp (SLXN) is developing RNA interference, establishing a foundation for future licensing agreements with pharma behemoths. Business success depends on the suppression of oncogenes rather than macroeconomics, which only affects multiples and the terms of secondary offerings.

silexion.com (SLXN) - Tingkat wutah pendapatan sajrone kuartal saka 17.08.2024 nganti 22.11.2026

Silexion (SLXN) - rincian metrik lan laporan keuangan

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis umum perusahaan:silexion.com (SLXN)
Barang unggulan Silexion Therapeutics Corp.

This indicator measures the growth rate of operating income as a percentage of the previous reporting period, allowing for a real-time assessment of business scaling dynamics. By analyzing quarterly revenue changes, an investor can confirm the commercialization efficiency of siRNA drugs for pancreatic cancer therapy, which is critical for evaluating the viability of the biotech startup Silexion Therapeutics Corp (SLXN).

Pesaing utama

INCY - Wutah pendapatan kuartal marang kuartal|Owah-owahan pendapatan dibandhingake kuartal kepungkur HUTCHMED (HCM)|NUVB: Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Day One Bio DAWN|Wutah dodolan triwulanan MNPR|Tingkat wutah pendapatan sajrone kuartal Inhibrx Biosciences INBX|Wutah dodolan triwulanan IMAB (I-Mab Biopharma Co., Ltd.)|FENC (Fennec Pharmaceuticals Inc.) - Tambahing pendapatan triwulanan|Heron Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal NVCT (Nuvectis Pharma)|Coherus BioSciences, Inc. - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan CRBP (Corbus Pharma)|CRDF: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal beyondspringpharma.com (BYSI)|Wutah pendapatan kuartal marang kuartal bioatla.com|LIXT: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan CTXR|Wutah pendapatan triwulanan Cellectar Corp (CLRB)|Wutah pendapatan kuartal marang kuartal BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Dinamika pendapatan kuartal marang kuartal|APRE: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Kazia Therapeutics Limited|NuCana plc (NCNA) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan triwulanan Chimerix, Inc|Wutah dodolan triwulanan CYCC|Wutah dodolan triwulanan G1 Therapeutics (GTHX)|Wutah pendapatan kuartal marang kuartal Kronos Bio Corporation (KRON)|Kintara - Wutah dodolan kuartal marang kuartal|Oncternal Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal PRTG (Portage)